The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II trial of CX-01 with standard therapy in elderly patients with acute myeloid leukemia (AML).
 
Tibor Kovacsovics
Consulting or Advisory Role - Celgene; Novartis
Research Funding - Abbvie; Novartis; Pfizer
 
Moshe Yair Levy
No Relationships to Disclose
 
Rachel J. Cook
Travel, Accommodations, Expenses - Syros Pharmaceuticals
 
Jonathan E. Kolitz
Consulting or Advisory Role - Abbvie; Daiichi Sankyo; Magellan Health; Novartis; Verastem
 
Peter Westervelt
No Relationships to Disclose
 
William Bruce Donnellan
No Relationships to Disclose
 
Robert K. Stuart
No Relationships to Disclose
 
John Leonard Reagan
Employment - Allergan (I)
Honoraria - Alexion Pharmaceuticals
Consulting or Advisory Role - Celgene; Teva
Speakers' Bureau - Alexion Pharmaceuticals
Travel, Accommodations, Expenses - Teva
 
Michaela L. Tsai
No Relationships to Disclose
 
Matthew Joseph Wieduwilt
Stock and Other Ownership Interests - Reata Pharmaceuticals
Research Funding - ADC Therapeutics (Inst); Amgen (Inst); Cantex (Inst); Jazz Pharmaceuticals (Inst); Merck (Inst); Shire (Inst); Sigma-Tau (Inst)
 
Michael B. Maris
No Relationships to Disclose
 
Don A. Stevens
No Relationships to Disclose
 
Jay Yang
No Relationships to Disclose
 
Cecilia Arana-Yi
No Relationships to Disclose
 
Hana Safah
No Relationships to Disclose
 
Stephen Garrett Marcus
Employment - Cantex Pharmaceuticals
Leadership - Cantex Pharmaceuticals
Stock and Other Ownership Interests - Cantex Pharmaceuticals
 
Paul J. Shami
Employment - JSK Therapeutics
Leadership - Bastion Biologics; JSK Therapeutics; Lone Star Thiotherapies
Stock and Other Ownership Interests - Bastion Biologics; JSK Therapeutics; Lone Star Thiotherapies
Research Funding - Amgen; Aptevo Therapeutics; Cantex Pharmaceuticals; Pfizer
Patents, Royalties, Other Intellectual Property - JSK Therapeutics